Literature DB >> 17965845

[Medication-induced impairment of renal function: what is important?].

B K Krämer1, M Banas, B Banas.   

Abstract

Non-steroidal antiphlogistics and COX-2 inhibitors routinely cause sodium retention and a blood pressure increase by about 5 mmHg, a decrease in renal function (by about 10 ml/min) and in 1-2% an acute renal failure. Prevention is possible by short-term, low-dose application, avoidance of dehydration, controlling serum creatinine levels 1 week after start of treatment in high-risk groups. Aminoglycosides cause acute renal failure in 10-20% which can be prevented by once daily dosing, meticulous drug monitoring. Radio contrast media cause, mostly dependent on baseline renal function, in 0-50% a radiocontrast-induced nephropathy. This can be prohibited with hydration, low volume of contrast medium, and low- (or iso)osmolar contrast medium. New preparations of vancomycin go along with a greatly reduced rate of nephrotoxicity. Drug monitoring and avoidance of a combination therapy with aminoglycosides will help to reduce toxicity. Medication-induced acute interstitial nephritis is a relevant differential diagnosis in acute renal failure: stop implicated medication, consider steroid application!

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965845     DOI: 10.1007/s00108-007-1960-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  13 in total

1.  A primer in radiocontrast-induced nephropathy.

Authors:  B K Krämer; M Kammerl; F Schweda; M Schreiber
Journal:  Nephrol Dial Transplant       Date:  1999-12       Impact factor: 5.992

2.  Benefit of acetylcysteine for prevention of contrast-induced nephropathy after primary angioplasty.

Authors:  Bernhard K Krämer; Ute Hoffmann
Journal:  Nat Clin Pract Nephrol       Date:  2007-01

Review 3.  Clinical practice. Preventing nephropathy induced by contrast medium.

Authors:  Brendan J Barrett; Patrick S Parfrey
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

Review 4.  Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence.

Authors:  Sean M Bagshaw; Finlay A McAlister; Braden J Manns; William A Ghali
Journal:  Arch Intern Med       Date:  2006-01-23

5.  Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group.

Authors:  F Liaño; J Pascual
Journal:  Kidney Int       Date:  1996-09       Impact factor: 10.612

6.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Authors:  M Tepel; M van der Giet; C Schwarzfeld; U Laufer; D Liermann; W Zidek
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

Review 7.  Acute renal failure.

Authors:  Norbert Lameire; Wim Van Biesen; Raymond Vanholder
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

8.  Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline.

Authors:  C M Erley; S H Duda; D Rehfuss; B Scholtes; J Bock; C Müller; H Osswald; T Risler
Journal:  Nephrol Dial Transplant       Date:  1999-05       Impact factor: 5.992

9.  Spectrum of acute renal failure in the intensive care unit: the PICARD experience.

Authors:  Ravindra L Mehta; Maria T Pascual; Sharon Soroko; Brandon R Savage; Jonathan Himmelfarb; T Alp Ikizler; Emil P Paganini; Glenn M Chertow
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

Review 10.  Renal cyclooxygenase-2 (COX-2). Physiological, pathophysiological, and clinical implications.

Authors:  Bernhard K Krämer; Martin C Kammerl; Martin Kömhoff
Journal:  Kidney Blood Press Res       Date:  2003-12-23       Impact factor: 2.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.